The manufacturing facility, operated by NRB Pharma Zambia Limited, was officially inaugrated on April 26, 2017 by His Excellency The President of Republic of Zambia Mr. Edgar Chagwa Lungu.
The plant has an installed capacity to manufacture 300 - 400 million tablets annually. Initially, NRB Pharma will cater to Zambia, but later will expand and cater to huge demands in sub-Saharan Africa.
NRB Pharma will produce anti-bacterial, anti-panadomic, anti-biotics, anti-tuberculosis tablets etc. Once the WHO approval is certified, the firm will manufacture anti-malarial, anti-retroviral drugs for HIV / AIDS.
Plant officially inaugrated by His Excellency The President of Republic of Zambia Mr. Edgar Chagwa Lungu.